In the context of aging-related brain injury, pre-clinical studies have been describing the role of myeloperoxidase (MPO) in neurodegenerative diseases, such as Alzheimer's disease,11 Parkinson's disease,12 and multiple sclerosis.13 Here, MPO is linked to early-onset autosomal dominant Alzheimer disease.